For Alzheimer’s Disease (AD) in particular, there is a strong link between biomarkers (i.e., β-amyloid accumulation, tau accumulation, neurodegeneration) and symptoms (i.e., cognitive decline)1,2,7,8. Here, MAPT is linked to Alzheimer disease.